CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-24 | MORRISSEY MICHAEL President and CEO | Gift | +67,374 | 1,059,683 | ||
| 2021-02-24 | COHEN CHARLES Director | Exercise or conversion | +40,000 | $3.38 | $135K | 221,375 |
| 2021-02-24 | COHEN CHARLES Director | Sale | −40,000 | $22.69 | $908K | 181,375 |
| 2021-02-24 | COHEN CHARLES Director | Exercise or conversion · Option (right to buy) | −40,000 | 0 | ||
| 2021-02-23 | WILLSEY LANCE Director | Exercise or conversion | +40,000 | $3.38 | $135K | 464,415 |
| 2021-02-23 | WILLSEY LANCE Director | Sale | −39,200 | $21.92 | $859K | 425,215 |
| 2021-02-23 | WILLSEY LANCE Director | Sale | −800 | $22.34 | $18K | 424,415 |
| 2021-02-23 | WILLSEY LANCE Director | Exercise or conversion · Option (right to buy) | −40,000 | 0 | ||
| 2021-02-22 | POSTE GEORGE Director | Exercise or conversion | +40,000 | $3.38 | $135K | 197,992 |
| 2021-02-22 | POSTE GEORGE Director | Exercise or conversion · Option (right to buy) | −40,000 | 0 | ||
| 2021-02-22 | MARCHESI VINCENT T Director | Sale | −24,097 | $22.29 | $537K | 66,115 |
| 2021-02-18 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Exercise or conversion | +50,000 | $1.70 | $85K | 590,597 |
| 2021-02-18 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Sale | −50,000 | $22.35 | $1.1M | 540,597 |
| 2021-02-18 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Exercise or conversion · Option (right to buy) | −50,000 | 100,000 | ||
| 2021-02-17 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Exercise or conversion | +50,000 | $1.70 | $85K | 590,597 |
| 2021-02-17 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Sale | −50,000 | $22.50 | $1.1M | 540,597 |
| 2021-02-17 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Exercise or conversion · Option (right to buy) | −50,000 | 150,000 | ||
| 2021-02-16 | WILLSEY LANCE Director | Sale | −50,000 | $21.90 | $1.1M | 424,415 |
| 2021-02-16 | FELDBAUM CARL B Director | Exercise or conversion | +20,000 | $3.38 | $68K | 28,521 |
| 2021-02-16 | FELDBAUM CARL B Director | Sale | −20,000 | $21.96 | $439K | 8,521 |
Page 35 of 42 · 836 trades